For personal use. Only reproduce with permission from The Lancet. The announcement on July 23 this year of proposals for a European Centre for Disease Prevention and Control (ECDC) produced surprisingly little reaction or comment. The type of organisation that European Union (EU) health and consumer protection commissioner David Byrne has proposed is very different from the European equivalent of the US Centers for Disease Control and Prevention (CDC), for which influential groups have been campaigning for several years.
In 1998 a group of scientists met in Montpellier, France, to formulate plans for a European Centre for Infectious Diseases. What they had in mind was a "centralised structure with walls" along the lines of the European Molecular Biology Laboratory in Heidelberg, Germany. However, this project failed to gain support from the EU. Instead, the centre that Byrne plans to have running by 2005 will have walls, but those walls will contain offices only, without diagnostic laboratories or research facilities. The ECDC will have an initial staff of 35, growing to 70 by 2007. Its budget will be €4·735 million in its first year, projected to grow to €14·303 million in 2007. These figures are modest compared with the CDC's 8500 staff and budget of $7·2 billion (€6·13 billion) in 2003. And the ECDC will deal only with communicable diseases, unlike the CDC, which concerns itself with many other aspects of human health such as injury prevention, occupational health, birth defects, and cancer surveillance.
EU collaboration on infectious diseases has a history going back to the early 1990s, starting with a network on communicable diseases in 1991. In 1999 the system was beefed up when the network for epidemiological surveillance and control of communicable diseases began work. This network has two main components: a system that links surveillance by national institutes of a specified list of communicable diseases; and an early warning and response system (EWRS) designed to alert publichealth authorities in member states and the European Commission to outbreaks with multinational significance. The EWRS is an internet-based system that allows exchange of opinions on risk assessment and risk management.
However, EU provisions for cooperation on communicable diseases were insufficient for Byrne, who in December 2001 described Europe's resources for an act of bioterrorism as "woefully inadequate". In April 2002, Byrne announced plans for a European centre for infectious diseases with its own staff and budget. These plans gained momentum during the outbreak of severe acute respiratory syndrome (SARS) earlier this year, during which it became apparent that the EU network was sufficient to monitor the spread of SARS but not to advise on or decide measures to control the disease.
Among the tasks envisioned for the ECDC are harmonisation of surveillance methodologies across Europe, providing scientific opinions and technical assistance, supporting preparedness planning for health emergencies, and providing a rapid response to health threats. It will also incorporate the activities of the existing surveillance network. The ECDC will not replace public-health institutions in member states of the EU; instead, it will act as a coordination, resource, and support centre on which these countries can call. Plans for the ECDC must be approved by the European Parliament before the centre can become a reality. A decision is hoped to be made at the end of 2003.
In 2004 the EU will expand by ten countries, bringing the number of member states to 25. Given that the public-health infrastructure of some of these prospective members is under pressure from rapidly expanding epidemics of HIV and tuberculosis, the support that the ECDC will provide is to be welcomed. As planned, the ECDC might also bring consistency to surveillance, testing, and reporting methods across Europe, and it should end the current unfortunate situation where experts from several member countries participate in an outbreak investigation but report back separately to their national bodies. Whether the ECDC will prove to be the seed for an institution that will eventually rival the CDC, only time will tell.
Two key components of the ECDC remain to be decided: the name of the centre's director, and its location. The scramble for these prestigious positions will likely generate more controversy than the nature of the centre itself.
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